Lowenstein Sandler represented Goldeneye 1995, LLC, an affiliate of Greg Kidd, in its $125 million acquisition of a controlling interest in USBC, Inc. (NYSE American: USBC), formerly Know Labs, Inc. (NYSE American: KNW).
Know Labs is a publicly traded, industry-leading technology company developing transformative financial services and non-invasive health monitoring solutions. Under the leadership of newly appointed Chairman and CEO, Greg Kidd, Know Labs has begun its transition into a multi-disciplinary enterprise that also strategically invests in pioneering technologies spanning digital assets and banking.
Subsequent to closing, the company's corporate legal name has changed to USBC, Inc., and its ticker symbol has changed from KNW to USBC, unveiling a new vision centered on the USBC token.
Under the terms of the previously announced agreement, Goldeneye 1995 contributed 1,000 Bitcoin and $15 million in cash to acquire 357.8 million new common shares.
The Lowenstein team included Daniel L. Forman, Trevor A. Levine, Annie Nazarian Davydov, Andrew E. Graw, Lauren VanderDrift, Taryn E.Cannataro, Revel Atkinson, Donna Calia, and Anthony C. Santiago.
